T2DM is characterized by hyperinsulinemia as reduced insulin receptor expression and receptor-activating enzymes, leading to the deposition of amyloid beta (Aβ) and Tau proteins (Arnold et al., 2018). Here, INSR is linked to Hyperinsulinemia.